Last month we addressed the under-discussed issue of lipohypertrophy. Lori Berard, chair of the Canadian Forum for Injection Techniques, helped…
Category: CGMs, Meters & Pumps
The U.S. FDA has authorized marketing of the Tandem Diabetes Care Control-IQ Technology, an interoperable automated glycemic controller device…
This past holiday weekend, as hundreds of thousands of loved ones caring for people with diabetes know, the Dexcom Follow app stopped working for…
Sponsored Post:
Accuracy is a range, not an exact number. Here are the variables that apply to all FDA-approved glucose meters.
Every time you…
Which technology will better improve your blood sugar management and quality of life: an insulin pump, or a continuous glucose monitor (CGM)?…
“Very few companies would make the bet that we’re making,” Kevin Sayer.
In the first half of our interview with Dexcom CEO Kevin Sayer, we…
ASweetLife was lucky enough to score an interview with Kevin Sayer, the President & CEO of Dexcom.
We are publishing our interview in two parts.…
On June 27, 2019, the FDA issued a warning patients and health care providers that certain Medtronic MiniMed™ insulin pumps have potential cybersecurity…
Are two hormones better than one? A new clinical trial aims to find out.
Massachusetts startup Beta Bionics and Danish biotech firm Zealand Pharma…
Medtronic and Tidepool, a nonprofit organization dedicated to making diabetes data more accessible, actionable and meaningful, have agreed…